Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes

Table 1

Comparison of demographic and clinical features in SLE Zoster and SLE Non-Zoster patients.

Characteristics	Cases	Controls	𝑃 value
	SLE with Zoster (𝑛=32) 𝑁 (%)	SLE without Zoster (𝑛=64) 𝑁 (%)
Sex
Male	2 (6.3)	4 (6.3)
Female	30 (93.8)	60 (93.8)
Race			.7656
Arabs	30 (93.8)	61 (95.3)
Non Arabs	2 (6.3)	3 (4.7)
Nephritis	18 (56.3)	28 (43.8)	.2474
Cerebritis	2 (6.3)	2 (3.1)	.5075
Serositis	9 (28.1)	13 (20.3)	.4089
Leucopenia	17 (53.1)	20 (31.2)	.0407^∗
Thrombocytopenia	8 (25.0)	11 (17.2)	.3879
Hemolytic anemia	11 (34.4)	9 (14.1)	.0344^∗
Cyclo IV	14 (43.8)	13 (20.3)	.0223^∗
MPSL	16 (50.0)	12 (18.8)	.0026^∗
Azathioprine	14 (43.8)	20 (31.2)	.2336
MMF	6 (18.8)	6 (9.4)	.2318

∗significant (𝑃<.05), Cylo IV: intravenous cyclophosphamide, MPSL:methyl prednisolone, MMF: mycophenolate mofetil.